The Dutch Ministry of Health has placed an order with BD (Becton, Dickinson and Company), a global medical technology company, to supply nine million of its rapid antigen tests for the BD Veritor Plus System that helps in detecting the SARS-CoV-2 infection in symptomatic individuals within 15 minutes. Approximately 1.2 million tests are expected to be delivered by mid-November.
The Institute of Inflammation, Immunology and Infectious Disease at Purdue University has collaborated with IdentifySensors Biologics, a technology firm, to develop a rapid diagnostic platform for detecting the SARS-CoV-2 virus and other pathogens. The platform will also detect infections such as influenza, dengue, Zika, HIV/AIDS, Lyme disease, hepatitis C, mumps, chickenpox, measles, foodborne pathogens, and methicillin-resistant staphylococcus Aureus (MRSA).
Hygea Precision Medicine, a precision medicine software company, announced that it has collaborated with testing-as-a-service (TaaS) provider 1health.io to deliver Covid-19 saliva tests across the country, which are designed to be easy and convenient to administer remotely.
Alveo Technologies announced that it has been awarded a grant from the Bill & Melinda Gates Foundation to test the use and performance of its Covid-19 testing platform, be.well. If successful, the company will look to further its development and manufacturing of the platform, which the company says is as accurate as a PCR test while providing rapid test results via smartphones.